Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-09-036047
Filing Date
2009-07-22
Accepted
2009-07-22 15:58:35
Documents
1
Period of Report
2009-07-20

Document Format Files

Seq Description Document Type Size
1 KESSEL - SYMPHONY PURCHASE OPTION EXERCISE rrd248877.html 4  
1 KESSEL - SYMPHONY PURCHASE OPTION EXERCISE rrd248877.xml 4 3998
  Complete submission text file 0001181431-09-036047.txt   5763
Mailing Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 650-635-7000
OXIGENE INC (Issuer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 950 PARK AVE APT. 11A NEW YORK NY 10028
Business Address
KESSEL MARK (Reporting) CIK: 0001222013 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-21990 | Film No.: 09957193